Annual SG&A
$2.13 M
-$353.80 K-14.27%
01 December 2022
Summary:
CERo Therapeutics Holdings annual selling, general & administrative expenses is currently $2.13 million, with the most recent change of -$353.80 thousand (-14.27%) on 01 December 2022. CERO annual SG&A is now -14.27% below its all-time high of $2.48 million, reached on 01 December 2021.CERO Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.63 M
+$194.10 K+7.97%
01 September 2024
Summary:
CERo Therapeutics Holdings quarterly selling, general & administrative expenses is currently $2.63 million, with the most recent change of +$194.10 thousand (+7.97%) on 01 September 2024. Over the past year, it has increased by +$2.37 million (+918.60%). CERO quarterly SG&A is now at all-time high.CERO Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$203.86 M
-$71.59 M-54.12%
01 September 2024
Summary:
CERo Therapeutics Holdings TTM selling, general & administrative expenses is currently -$203.86 million, with the most recent change of -$71.59 million (-54.12%) on 01 September 2024. Over the past year, it has dropped by -$205.98 million (-9729.88%). CERO TTM SG&A is now -433.14% below its all-time high of $5.06 million, reached on 01 September 2024.CERO TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CERO Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | +918.6% | -9729.9% |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
CERO Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -14.3% | at low | at high | +918.6% | -433.1% | at low |
5 y | 5 years | -14.3% | at low | at high | +918.6% | -433.1% | at low |
alltime | all time | -14.3% | at low | at high | +918.6% | -433.1% | at low |
CERo Therapeutics Holdings Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $2.63 M(+8.0%) | $5.06 M(+88.0%) |
June 2024 | - | $2.43 M(+843.4%) | $2.69 M(+27.2%) |
Sept 2023 | - | $258.00 K(-78.9%) | $2.12 M(+13.9%) |
June 2023 | - | $1.22 M(+91.2%) | $1.86 M(+191.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2023 | - | $638.30 K(-13.3%) | $638.30 K(-13.3%) |
Dec 2022 | $2.13 M(-14.3%) | - | - |
Mar 2022 | - | $736.30 K | $736.30 K |
Dec 2021 | $2.48 M | - | - |
FAQ
- What is CERo Therapeutics Holdings annual selling, general & administrative expenses?
- What is the all time high annual SG&A for CERo Therapeutics Holdings?
- What is CERo Therapeutics Holdings quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for CERo Therapeutics Holdings?
- What is CERo Therapeutics Holdings quarterly SG&A year-on-year change?
- What is CERo Therapeutics Holdings TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for CERo Therapeutics Holdings?
- What is CERo Therapeutics Holdings TTM SG&A year-on-year change?
What is CERo Therapeutics Holdings annual selling, general & administrative expenses?
The current annual SG&A of CERO is $2.13 M
What is the all time high annual SG&A for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high annual selling, general & administrative expenses is $2.48 M
What is CERo Therapeutics Holdings quarterly selling, general & administrative expenses?
The current quarterly SG&A of CERO is $2.63 M
What is the all time high quarterly SG&A for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high quarterly selling, general & administrative expenses is $2.63 M
What is CERo Therapeutics Holdings quarterly SG&A year-on-year change?
Over the past year, CERO quarterly selling, general & administrative expenses has changed by +$2.37 M (+918.60%)
What is CERo Therapeutics Holdings TTM selling, general & administrative expenses?
The current TTM SG&A of CERO is -$203.86 M
What is the all time high TTM SG&A for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high TTM selling, general & administrative expenses is $5.06 M
What is CERo Therapeutics Holdings TTM SG&A year-on-year change?
Over the past year, CERO TTM selling, general & administrative expenses has changed by -$205.98 M (-9729.88%)